# DAPSONE
> **ANDA212657** · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL · Approved 2023-11-01
## Drug
- **FDA Application Number:** ANDA212657
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DAPSONE
- **Generic name:** Dapsone
- **Active ingredients:** DAPSONE
- **Dosage form:** GEL
- **Route:** TOPICAL
- **Marketing status:** Discontinued
- **Sponsor:** PADAGIS ISRAEL
- **First approval:** 2023-11-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212657)
---
*MORVS · CC0 1.0*